T Cell Receptor Depletion in Stem Cell Transplant
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 48 patients (estimated)
- Sponsors
- University of Minnesota - Masonic Cancer Center
- Tags
- Adoptive Cellular Therapy, Chemotherapy, Monoclonal Antibody, T Cell (Allogeneic), CD20, Radiation Therapy, Steroid
- Trial Type
- Treatment
- Last Update
- 2 months ago
- SparkCures ID
- 1579
- NCT Identifier
- NCT03579875
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.